Evidence map›Paper›PMID 33305805›Full record

ArticleThe international journal of neuropsychopharmacology2021

Converging Evidence on D-Amino Acid Oxidase-Dependent Enhancement of Hippocampal Firing Activity and Passive Avoidance Learning in Rats.

Lili Veronika Nagy, Zsolt Kristóf Bali, Gábor Kapus, Péter Pelsőczi, Bence Farkas, Balázs Lendvai, György Lévay, István Hernádi

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy.Frontiers in molecular neuroscience · 2021
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lili Veronika NagyDepartment of Experimental Zoology and Neurobiology, Faculty of Sciences, University of Pécs, Pécs, Hungary.
Zsolt Kristóf BaliSzentágothai Research Center, Center for Neuroscience, University of Pécs, Pécs, Hungary.ORCID 0000-0003-0712-0788
Gábor KapusPharmacological and Drug Safety Research, Gedeon Richter Plc, Budapest, Hungary.
Péter PelsőcziPharmacological and Drug Safety Research, Gedeon Richter Plc, Budapest, Hungary.
Bence FarkasPharmacological and Drug Safety Research, Gedeon Richter Plc, Budapest, Hungary.
Balázs LendvaiPharmacological and Drug Safety Research, Gedeon Richter Plc, Budapest, Hungary.
György LévayPharmacological and Drug Safety Research, Gedeon Richter Plc, Budapest, Hungary.
István HernádiDepartment of Experimental Zoology and Neurobiology, Faculty of Sciences, University of Pécs, Pécs, Hungary.ORCID 0000-0001-7882-4817
Gedeon Richter (Hungary) · HUUniversity of Pecs · HUSemmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundN-methyl-D-aspartate (NMDA) receptor activation requires the binding of a co-agonist on the glycine-binding site. D-serine is the main endogenous co-agonist of NMDA receptors, and its availability significantly depends on the activity of the metabolic enzyme D-amino acid oxidase (DAAO). Inhibition of DAAO increases the brain levels of D-serine and modulates a variety of physiological functions, including cognitive behavior.

methodsHere, we examined the effects of a novel 4-hydroxypyridazin-3(2H)-one derivative DAAO inhibitor, Compound 30 (CPD30), on passive avoidance learning and on neuronal firing activity in rats.

resultsD-serine administration was applied as reference, which increased cognitive performance and enhanced hippocampal firing activity and responsiveness to NMDA after both local and systemic application. Similarly to D-serine, CPD30 (0.1 mg/kg) effectively reversed MK-801-induced memory impairment in the passive avoidance test. Furthermore, local iontophoretic application of CPD30 in the vicinity of hippocampal pyramidal neurons significantly increased firing rate and enhanced their responses to locally applied NMDA. CPD30 also enhanced hippocampal firing activity after systemic administration. In 0.1- to 1.0-mg/kg doses, CPD30 increased spontaneous and NMDA-evoked firing activity of the neurons. Effects of CPD30 on NMDA responsiveness emerged faster (at 10 minutes post-injection) when a 1.0-mg/kg dose was applied compared with the onset of the effects of 0.1 mg/kg CPD30 (at 30 minutes post-injection).

conclusionsThe present results confirm that the inhibition of DAAO enzyme is an effective strategy for cognitive enhancement. Our findings further facilitate the understanding of the cellular mechanisms underlying the behavioral effects of DAAO inhibition in the mammalian brain.

Indexed as

Action PotentialsAnimalsAvoidance LearningBehavior, AnimalD-Amino-Acid OxidaseEnzyme InhibitorsExcitatory Amino Acid AgonistsHippocampusMaleMemory DisordersN-MethylaspartateNootropic AgentsPyramidal CellsPyridinium CompoundsRatsRats, Wistarcompound 30D-Amino-Acid OxidaseEnzyme InhibitorsExcitatory Amino Acid AgonistsN-MethylaspartateNootropic AgentsPyridinium CompoundsDAAOD-serinehippocampusmemoryNMDA receptor

Identifiers

PMID33305805
PMCPMC8130201
OpenAlexW3111488079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.